Pieris Pharmaceuticals, Inc.

  • Home
  • About
  • Platform
  • Pipeline
  • Patients
  • Investors
    • Overview
    • News & Events
    • Publications
    • Presentations
    • Financial Results
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
    • Job Openings
  • Contact
  • News & Events

  • Overview
  • Press Releases
  • Media
  • IR Calendar
  • Email Alerts
Apr 02, 2019 8:00am EDT

Pieris Pharmaceuticals Presents Preclinical Data for GPC3/4-1BB Bispecific PRS-342 at the 2019 American Association for Cancer Research (AACR) Annual Meeting

Mar 12, 2019 7:00am EDT

Pieris Pharmaceuticals Reports 2018 Year-End Cash Position and Provides Corporate Update

Mar 06, 2019 8:00am EST

Pieris Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference

Mar 05, 2019 8:00am EST

Pieris Pharmaceuticals to Host Full-Year 2018 Investor Call and Corporate Update on March 12, 2019

Nov 08, 2018 8:00am EST

Pieris Pharmaceuticals to Present at Investor Conferences in November

Nov 07, 2018 7:00am EST

Pieris Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Oct 31, 2018 8:00am EDT

Pieris Pharmaceuticals to Host Third Quarter 2018 Investor Call and Corporate Update on November 7, 2018

Oct 25, 2018 8:16am EDT

Pieris Pharmaceuticals Appoints Matthew L. Sherman, M.D., to its Board of Directors

Oct 02, 2018 8:00am EDT

Pieris Pharmaceuticals to Present Preclinical Data for 4-1BB/PD-L1 Bispecific PRS-344/ONC0055 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Sep 25, 2018 8:00am EDT

Pieris Pharmaceuticals to Present at Investor Conferences in October

  • Previous
  • 1…
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …25
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© 2023 Pieris Pharmaceuticals, Inc. All Rights Reserved.
Imprint Privacy Policy Disclaimer Sitemap Contact Us Manage Cookie Preferences